Items Tagged ‘antidepressants’

June 29, 2022

Mayo study validates threshold to determine when an antidepressant is ineffective

By Susan Murphy Susan Murphy (@susanmurphy)

Mayo Clinic researchers have validated a threshold designed to help determine if an antidepressant used for depression is working, but not well enough to be continued.

View full entry

Tags: #Dr. William Bobo, antidepressants, center for individualized medicine, depression, genomics, individualized medicine, major depressive disorder, medical research, personalized medicine


June 10, 2019

Meet William Bobo, M.D. – taking the guesswork out of finding the right depression therapy

By Sharon Rosen Sharon Rosen (@sharonhrosen)

Depression can touch every aspect of a person’s life – affecting the way they think, feel and behave. It is also the leading medical condition for those who complete suicide. Getting the right therapy is crucial. But for patients suffering from the disorder, finding an effective treatment often involves trial and error. That’s because it […]

View full entry

Tags: #Artificial Intelligence, #Center for Individualized Mediicine, #Dr. Arjun Athreya, #Dr. William Bobo, #individualized mediicne, #Mayo Clinic and Illinois Alliance for Technology-Based Healthcare, #mood disorders, #predictive algorithm, #selective serotonin reuptake inhibitors, #targeted therapies, #Treatment response, antidepressants


January 15, 2018

Artificial intelligence: Will a machine pick your next medication?

By Susan Buckles Susan Buckles (@susanbuckles)

What once may have seemed like a scene from a 22nd century sci-fi movie is reality today. High-speed, big data processing computers combine artificial intelligence with human know-how to crack complex health care conditions. This deep computer analysis may unveil new patterns that could bolster your health care provider’s ability to prescribe precise therapies, make […]

View full entry

Tags: #Artificial Intelligence, #Center for Computational Biotechnology and Genomic Medicine, #Dr. Ravishankar Iyer, #Machine learning, antidepressants, depression, Dr. Liewei Wang, genomics, mayo clinic, Mayo Clinic Center for Individualized Medicine, Precision Medicine, University of Illinois at Urbana-Champaign


March 17, 2017

The power of pharmacogenomics: one physician’s ‘aha moment’

By Sharon Rosen Sharon Rosen (@sharonhrosen)

Seeing is believing – that saying is especially true for Fadi Shamoun, M.D., a consultant and assistant professor in the Department of Cardiovascular Diseases at Mayo Clinic’s campus in Arizona. Dr. Shamoun was aware of the potential value of pharmacogenomics testing, which examines how a patient’s genetic makeup could impact the way he or she […]

View full entry

Tags: #anti-coagulation medication, #Dr. Fadi Shamoun, #drug-gene reactions, #PGx testing, #Warfarin, antidepressants, center for individualized medicine, mayo clinic, medical research, pharmacogenomics


September 30, 2016

Consulting your genetic blueprint to find the right medication for you

By Sharon Rosen Sharon Rosen (@sharonhrosen)

Selecting the wrong medication for a patient can have serious implications. For example, if you have depression, the wrong medication could actually cause dangerous side effects that make you feel worse. In fact, researchers in the growing field of pharmacogenomics, which identifies drug-gene reactions, have already discovered that an individual’s genetic characteristics can influence how […]

View full entry

Tags: #drug-gene reactions, #JAMA, #mental illness, #PrecisionMedicine, antidepressants, center for individualized medicine, depression, Dr. Mark Frye, individualized medicine, mayo clinic, pharmacogenomics, Psychiatry


June 27, 2016

Mayo Clinic Introduces Precision Medicine in Psychiatry

By Jeff Briggs Jeff Briggs (@JeffreyBriggs)

The right drug at the right dose at the right time. Faithful readers of the Center for Individualized Medicine blog already know we’re talking again about pharmacogenomics, or PGx. As we’ve explored in previous posts, these “right” goals drive pharmacogenomics — how genetics influence a person’s response to medications. But can pharmacogenomics and precision medicine […]

View full entry

Tags: antidepressants, center for individualized medicine, CYP2D6, depression, Dr. Mark Frye, Dr. Wayne Nicholson, genome, mental health, pharmacogenomics, Precision Medicine, Prozac, Psychiatry


Contact Us · Privacy Policy